Literature DB >> 26239501

Alternative Sampling Strategies for Cytochrome P450 Phenotyping.

Pieter M M De Kesel1, Willy E Lambert1, Christophe P Stove2.   

Abstract

Interindividual variability in the expression and function of drug metabolizing cytochrome P (CYP) 450 enzymes, determined by a combination of genetic, non-genetic and environmental parameters, is a major source of variable drug response. Phenotyping by administration of a selective enzyme substrate, followed by the determination of a specific phenotyping metric, is an appropriate approach to assess the in vivo activity of CYP450 enzymes as it takes into account all influencing factors. A phenotyping protocol should be as simple and convenient as possible. Typically, phenotyping metrics are determined in traditional matrices, such as blood, plasma or urine. Several sampling strategies have been proposed as an alternative for these traditional sampling techniques. In this review, we provide a comprehensive overview of available methods using dried blood spots (DBS), hair, oral fluid, exhaled breath and sweat for in vivo CYP450 phenotyping. We discuss the relation between phenotyping metrics measured in these samples and those in conventional matrices, along with the advantages and limitations of the alternative sampling techniques. Reliable phenotyping procedures for several clinically relevant CYP450 enzymes, including CYP1A2, CYP2C19 and CYP2D6, are currently available for oral fluid, breath or DBS, while additional studies are needed for other CYP450 isoforms, such as CYP3A4. The role of hair analysis for this purpose remains to be established. Being non- or minimally invasive, these sampling strategies provide convenient and patient-friendly alternatives for classical phenotyping procedures, which may contribute to the implementation of CYP450 phenotyping in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26239501     DOI: 10.1007/s40262-015-0306-y

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  147 in total

Review 1.  Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future.

Authors:  Magnus Ingelman-Sundberg
Journal:  Trends Pharmacol Sci       Date:  2004-04       Impact factor: 14.819

2.  Oral flurbiprofen metabolic ratio assessment using a single-point dried blood spot.

Authors:  Y Daali; C Samer; J Déglon; A Thomas; J Chabert; M Rebsamen; C Staub; P Dayer; J Desmeules
Journal:  Clin Pharmacol Ther       Date:  2012-01-11       Impact factor: 6.875

3.  LC-MS/MS analysis of dextromethorphan metabolism in human saliva and urine to determine CYP2D6 phenotype and individual variability in N-demethylation and glucuronidation.

Authors:  Ursula Lutz; Wolfgang Völkel; Roman W Lutz; Werner K Lutz
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2004-12-25       Impact factor: 3.205

4.  The cytochrome p450 homepage.

Authors:  David R Nelson
Journal:  Hum Genomics       Date:  2009-10       Impact factor: 4.639

Review 5.  The current status of sweat testing for drugs of abuse: a review.

Authors:  N De Giovanni; N Fucci
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

6.  Increase of cytochrome P450IA2 activity by omeprazole: evidence by the 13C-[N-3-methyl]-caffeine breath test in poor and extensive metabolizers of S-mephenytoin.

Authors:  K L Rost; H Brösicke; J Brockmöller; M Scheffler; H Helge; I Roots
Journal:  Clin Pharmacol Ther       Date:  1992-08       Impact factor: 6.875

7.  Salivary caffeine metabolic ratio in alcohol-dependent subjects.

Authors:  Veerapol Kukongviriyapan; Laddawan Senggunprai; Auemduan Prawan; Danu Gaysornsiri; Upa Kukongviriyapan; Jareerat Aiemsa-Ard
Journal:  Eur J Clin Pharmacol       Date:  2004-03-12       Impact factor: 2.953

8.  Evaluation of a [13C]-dextromethorphan breath test to assess CYP2D6 phenotype.

Authors:  J Steven Leeder; Robin E Pearce; Andrea Gaedigk; Anil Modak; David I Rosen
Journal:  J Clin Pharmacol       Date:  2008-09       Impact factor: 3.126

9.  The caffeine CO2 breath test: dose response and route of N-demethylation in smokers and nonsmokers.

Authors:  A N Kotake; D A Schoeller; G H Lambert; A L Baker; D D Schaffer; H Josephs
Journal:  Clin Pharmacol Ther       Date:  1982-08       Impact factor: 6.875

Review 10.  Clinical strategies to enhance the efficacy of nicotine replacement therapy for smoking cessation: a review of the literature.

Authors:  Matthew J Carpenter; Bianca F Jardin; Jessica L Burris; Amanda R Mathew; Robert A Schnoll; Nancy A Rigotti; K Michael Cummings
Journal:  Drugs       Date:  2013-04       Impact factor: 9.546

View more
  1 in total

1.  Evaluation of Potential Herb-Drug Interactions Between Shengmai Injection and Losartan Potassium in Rat and In Vitro.

Authors:  Zhenchao Niu; Tingting Qiang; Wenyong Lin; Yiping Li; Keyan Wang; Dan Wang; Xiaolong Wang
Journal:  Front Pharmacol       Date:  2022-04-20       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.